SCHEMBL22243155

SCHEMBL22243155

N#Cc1ccc2c(c1)c1cc(C#N)ccc1n2-c1ccc(C#N)c(-c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc2-n2c3ccc(C#N)cc3c3cc(C#N)ccc32)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
LMNA P02545 4/20 0.38
MAPK1 P28482 2/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP1A2 P05177 5/20 0.36
CYP3A4 P08684 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
CYP2D6 P10635 3/20 0.36
TSHR P16473 3/20 0.36
CYP2C19 P33261 2/20 0.36
CLK4 Q9HAZ1 2/20 0.36
HSD17B10 Q99714 2/20 0.36
CYP2C9 P11712 1/20 0.36
ABCG2 Q9UNQ0 7/20 0.35
ABCB1 P08183 3/20 0.35
NR3C1 P04150 1/20 0.34
TP53 P04637 2/20 0.33
TDP2 O95551 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22243154 0.97 CYP1A2 (0.36) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL22242975 0.94 ALDH1A1 (0.41) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL22243091 0.93 CYP1A2 (0.41) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL22242966 0.92 ALDH1A1 (0.39) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL22242973 0.91 ALDH1A1 (0.36) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL22242974 0.91 ALDH1A1 (0.39) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL22243157 0.91 ALDH1A1 (0.39) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL22242967 0.91 ALDH1A1 (0.39) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL22243214 0.91 CYP1A2 (0.41) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL22242969 0.90 NR3C1 (0.42) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11600783-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-03-07 US disclosed
US-20200235308-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235308-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OXER1, OR10J3, OXGR1 ALDH1A1 869/4885LMNA 4272/4885MAPK1 2648/4885
US-11600783-B2 Organic molecules for use in optoelectronic devices OR10J3, OR51E2, ALDH1A2 ALDH1A1 48/4885LMNA 4103/4885MAPK1 1657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.